Sign in Subscribe
COVID-19

Pneumonia Cases on the Rise in Peru's Vulnerable Populations

Strategic Insights

— 1 min read

The winter season has brought about a concerning increase in pneumonia cases among Peru's most vulnerable populations: children under 5 years old and older adults. According to the Ministry of Health (Minsa), these groups have been disproportionately affected by respiratory infections, including influenza, pneumonia, and COVID-19. The regions of Pasco, Huancavelica, Apurimac, Ucayali, and Arequipa have reported the highest rates of hospitalizations due to pneumonia.

Key Takeaways:

  • Children under 5 years old and older adults are the most affected by pneumonia and other respiratory infections in Peru.
  • The Ministry of Health (Minsa) has sufficient vaccines available nationwide to immunize against influenza, pneumococcus, COVID-19, and other respiratory infections.
  • Pneumonia is a common and potentially life-threatening illness caused by a lung infection and transmitted through close contact with infected people.
  • The winter season can exacerbate respiratory infections due to low temperatures, making it crucial for vulnerable populations to receive vaccination.
  • The regions of Pasco, Huancavelica, Apurimac, Ucayali, and Arequipa have reported high rates of hospitalizations due to pneumonia.
  • The Ministry of Health (Minsa) is urging parents and caregivers of children and the elderly to visit health facilities for vaccination.
  • Pneumonia can present in different forms, ranging from mild to life-threatening, and can be prevented with vaccination.

Statistics:

  • According to the National Center for Epidemiology and Disease Control (CDC Peru), hospitalizations due to pneumonia have been recorded in children under 5 years old and older adults.
  • The regions with the highest rate of episodes of acute respiratory infections are Pasco, Huancavelica, Apurimac, Ucayali, and Arequipa.
  • The Ministry of Health (Minsa) has sufficient vaccines available to immunize the population against influenza, pneumococcus, and COVID-19.

Sources:

  • Ministry of Health, Government of Peru (Minsa)
  • National Center for Epidemiology and Disease Control (CDC Peru)

Read more